Page last updated: 2024-08-24

imiquimod and paromomycin

imiquimod has been researched along with paromomycin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berman, J1
Bazarsky, E; El-On, J; Sneir, R1
Minodier, P; Parola, P1
Aguiar, MG; Carneiro, G; Fernandes, AP; Ferreira, LA1
Blanco, L; Calvo, A; Espuelas, S; Fernández-Rubio, C; Irache, JM; Larrea, E; Moreno, E; Nguewa, P; Sanmartín, C; Schwartz, J1

Reviews

3 review(s) available for imiquimod and paromomycin

ArticleYear
Clinical status of agents being developed for leishmaniasis.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11

    Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine

2005
Cutaneous leishmaniasis treatment.
    Travel medicine and infectious disease, 2007, Volume: 5, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine

2007
Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
    Expert opinion on drug delivery, 2012, Volume: 9, Issue:9

    Topics: Administration, Cutaneous; Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Delivery Systems; Humans; Imiquimod; Leishmaniasis, Cutaneous; Naphthoquinones; Paromomycin; Phosphorylcholine; Skin Absorption

2012

Other Studies

2 other study(ies) available for imiquimod and paromomycin

ArticleYear
Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    Experimental parasitology, 2007, Volume: 116, Issue:2

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiprotozoal Agents; Benzethonium; Drug Therapy, Combination; Imiquimod; Leishmania major; Leishmaniasis, Cutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Ointments; Paromomycin; Rabbits

2007
Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Journal of dermatological science, 2018, Volume: 92, Issue:1

    Topics: Animals; Antibodies; Antiprotozoal Agents; Cells, Cultured; Dermatitis; Disease Models, Animal; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Imiquimod; Inflammation Mediators; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Mice, Inbred BALB C; Neutrophil Infiltration; Paromomycin; Skin; Tumor Necrosis Factor-alpha

2018